Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07825532

Comparison of Induced Membrane Technique With Vascularized Fibula Flap for Pediatric Limb Reconstruction

This study has for goal to evaluate vascularised fibula flap and induced membrane for children's bone loss.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient under 18 years old
  • Procedure by induced membrane or vascularised fibula flap for limb reconstruction from 2000 to 2026

Exclusion criteria

  • Patient under 6 months follow up
  • Patient who underwent vascularised fibula flap with epiphysis

Treatment and study plan

limb reconstruction

Procedure
  • induced membrane
  • vascularised fibula

Primary outcomes

  1. Complete consolidation at 12 months

    Time frame: assessment of consolidation 12 months after surgical reconstruction, for induced membrane group the first time of surgery is considerred

    The measures will be evaluated on x-rays. Consolidation is considerred achieved when at least 3 out of 4 cortices are fused.

    Xrays are done on every consultations

Sponsors and collaborators

Lead sponsor

Central Hospital, Nancy, France

Other

Registry information

Official study title

Comparison of Induced Membrane Technique With Vascularized Fibula Flap for Pediatric Limb Reconstruction, a National French Study

Acronym: FIBMASC

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Sep 17, 2026
Registry last updated
Sep 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.